KC
Ken Cacciatore TD Cowen Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Arcutis Biotherapeutics
ARQT
$2.08B
| $17.33 | $50 |
189%
upside
| Outperform |
9 Aug ‘23
2 years ago |
|
2
Takeda Pharmaceutical
TAK
$48.2B
| $15.27 | $20 |
31%
upside
| Outperform |
16 May ‘23
2 years ago |
|
3
scPharmaceuticals
SCPH
$300M
| $5.58 | $25 |
348%
upside
| Outperform |
1 Dec ‘22
2 years ago |
|
4
Bausch + Lomb
BLCO
$5.49B
| $15.52 | $35 |
126%
upside
| Outperform |
11 May ‘22
3 years ago |
|
|
MOLN
5
Molecular Partners
MOLN
$134M
| $3.58 | $50 |
1,297%
upside
| Outperform |
13 Jul ‘21
4 years ago |
|
6
Protara Therapeutics
TARA
$118M
| $3.07 | $50 |
1,529%
upside
| Outperform |
19 Oct ‘20
4 years ago |
|
|
AMRN
7
Amarin Corp
AMRN
$306M
| $14.78 | $460 |
3,012%
upside
| Outperform |
2 Mar ‘20
5 years ago |
|